胎宝汤联合地屈孕酮治疗黄体功能不全性先兆流产患者的效果

doi:10.3760/cma.j.cn441417-20240605-10029

摘要/Abstract

摘要：

目的　探讨胎宝汤联合地屈孕酮对黄体功能不全性先兆流产患者的疗效及对内分泌水平和免疫功能指标的影响。方法　采用前瞻性临床对照研究，共纳入陕西省榆林市中医医院2021年4月至2023年3月收治的86例黄体功能不全性先兆流产患者。按照随机数字表法将患者分为研究组和对照组，每组43例。研究组年龄（29.39±4.48）岁，孕周（8.93±2.11）周；对照组年龄（28.89±4.35）岁，孕周（9.10±2.12）周。对照组给予地屈孕酮治疗，研究组在对照组基础上加用胎宝汤。两组均持续治疗4周。观察两组中医证候积分、保胎成功率、内分泌水平［血清孕酮（P）、雌二醇（E2）、人绒毛膜促性腺激素（β-hCG）］、免疫功能指标［CD4+、CD8+和CD4+/CD8+比值］及妊娠结局。采用t检验及χ2检验进行统计学分析。结果　治疗后，研究组腹痛消失时间、阴道止血时间和中医证候积分均低于对照组［（2.17±0.51）d比（2.53±0.49）d、（2.19±0.40）d比（2.48±0.47）d、（5.32±1.13）分比（6.23±1.07）分］，差异均有统计学意义（t=3.338、3.081、3.834，均P<0.05）。治疗后，研究组P、E2、β-hCG水平均较对照组高［（48.67±6.30）μg/L比（45.16±6.23）μg/L、（638.23±39.18）ng/L比（616.06±43.28）ng/L、（8 536.88±365.02）IU/L比（8 343.15±371.29）IU/L］，差异均有统计学意义（均P<0.05）。治疗后，研究组CD4+水平、CD4+/CD8+比值均较对照组低，CD8+水平较对照组高（35.55±3.61比37.27±4.10、1.26±0.33比1.48±0.32、28.24±3.82比26.16±4.01），差异均有统计学意义（t=2.065、3.138、2.463，均P<0.05）。研究组不良反应发生率与对照组比较［9.30%（4/43）比13.95%（6/43）］，差异无统计学意义（χ2=0.453，P>0.05）。研究组新生儿体质量高于对照组［（2 530.32±268.41）g比（2 423.31±223.26）g］，差异有统计学意义（χ2=2.010，P<0.05）。结论　胎宝汤联合地屈孕酮治疗黄体功能不全性先兆流产患者可以有效提高患者的内分泌水平，并改善免疫功能，从而提高治疗效果，降低流产风险。

关键词: 黄体功能不全, , , 先兆流产, , , 胎宝汤, , , 地屈孕酮, , , 内分泌, , , 免疫功能

Abstract:

Objective　To investigate the effect of Taibao Tang combined with dydrogesterone for patients with threatened miscarriage due to luteal insufficiency and its impact on their endocrine and immune parameters. Methods　This study was a prospective clinical controlled trial. Eighty-six patients with threatened miscarriage due to luteal insufficiency treated at Yulin Traditional Chinese Medicine Hospital from April 2021 to March 2023 were selected, and were divided into a control group and a study group by the random number table method, with 43 cases in each group. The study group were (29.39±4.48) years old and (8.93±2.11) weeks pregnant. The control group were (28.89±4.35) years old and (9.10±2.12) weeks pregnant. The control group took dydrogesterone, and the treatment group dydrogesterone and Taibao Tang. The scores of traditional Chinese medicine (TCM) syndrome, pregnancy maintenance rates, endocrine levels [serum progesterone (P), estradiol (E2), and human chorionic gonadotropin (β-hCG)], immune parameters ( CD4+, CD8+, and CD4+/CD8+ ratio), and pregnancy outcomes were compared between the two groups. t andχ² tests were used for the statistical analysis. Results　After the treatment, the time for the disappearance of abdominal pain, time for vaginal hemostasis, and score of TCM syndromes in the study group were lower than those in the control group [(2.17±0.51) d vs.(2.53±0.49) d, (2.19±0.40) d vs. (2.48±0.47) d, 5.32±1.13 vs. 6.23±1.07], with statistical differences (t=3.338, 3.081, and 3.834; all P<0.05). After the treatment, the scores of P, E2, and β-hCG in the study group were higher than those in the control group [(48.67±6.30) μg/L vs.(45.16±6.23) μg/L, (638.23±39.18) ng/L vs. (616.06±43.28) ng/L, and (8 536.88±365.02) IU/L vs. (8 343.15±371.29) IU/L], with statistical differences (all P<0.05). After the treatment, the levels of CD4+, CD4+/CD8+, CD8+ in the study group were better than those in the control group (35.55±3.61 vs. 37.27±4.10，1.26±0.33 vs. 1.48±0.32，28.24±3.82 vs.26.16±4.01), with statistical differences (t=2.065, 3.138, and 2.463; all P<0.05). There was no statistical differencein the incidence rate of adverse reactions between the study group and the control group [9.30%(4/43) vs. 13.95%(6/43); χ²=0.453; P>0.05]. The newborns' body weight in the study group was higher than that in the control group [(2 530.32±268.41) g vs. (2 423.31±223.26) g], with a statistical difference (t=2.010; P<0.05). Conclusion　Taibao Tang combined with dydrogesterone in the treatment of patients with with threatened miscarriage due to luteal insufficiency can improve their endocrine levels, immune function, and treatment effect, and reduce the risk of miscarriage.

Key words: Luteal insufficiency, , Threatened miscarriage, , Taibao Tang, , Dydrogesterone, , Endocrine, , Immune function

窦娜刘筱茂李春春张媛霍艳宁冯艳霞. 胎宝汤联合地屈孕酮治疗黄体功能不全性先兆流产患者的效果 [J]. 国际医药卫生导报, 2025, 31(10): 1724-1728.

Dou Na, Liu Xiaomao, Li Chunchun, Zhang Yuan, Huo Yanning, Feng Yanxia.

Effect of Taibao Tang combined with dydrogesterone for patients with with threatened miscarriage due to luteal insufficiency [J]. International Medicine and Health Guidance News, 2025, 31(10): 1724-1728.

参考文献

[1]韩永梅,吕宣宣. 补肾活血方对抗磷脂抗体阳性复发性流产患者外周血microRNA-423-5p表达的影响及疗效分析[J]. 中国现代医学杂志,2023,33(2):48-53. DOI:10.3969/j.issn.1005-8982.2023.02.008.

[2]吴晓荣,詹萌,曹意苒. 戊酸雌二醇片联合二甲双胍治疗不孕症患者的效果[J]. 国际医药卫生导报,2024,30(7):1186-1189. DOI:10.3760/cma.j.issn.1007-1245. 2024.07.026.

[3]李辉,郭艳霞,孙昕卉,等. 降调节方案和拮抗剂方案助孕≥40岁合并卵巢储备功能减退患者的结局分析[J]. 国际医药卫生导报,2023,29(9):1223-1227. DOI:10.3760/cma.j.issn.1007-1245.2023.09.010.

[4]边有鑫,张艳,王文东. 低分子肝素治疗复发性流产效果及患者外周血Th1/Th2各型细胞因子及子宫动脉血流阻力变化[J]. 中国计划生育学杂志,2023,31(2):286-290. DOI:10.3969/j.issn.1004-8189.2023.02.010.

[5]于珍,唐英,秦茜羽. 微血管血流成像技术评估复发性流产与正常育龄期女性子宫内膜微血流血管化指数差异的价值[J]. 实用妇产科杂志,2023,39(11):861-864.

[6]罗希,赵淑云,周桦,等. 拮抗剂方案黄体支持中添加GnRH-a对新鲜周期临床结局的影响[J]. 实用妇产科杂志,2023,39(12):939-943.

[7]谢幸,苟文丽.妇产科学[M]. 8版.北京:人民卫生出版社,2013:310-313.

[8]国家食品药品监督管理局. 中药新药临床研究指导原则[S]. 北京:中国医药科技出版社,2002:145-146.

[9]陈俭勤,邓小中,姚周平. 地屈孕酮片治疗黄体功能不全所致先兆流产疗效[J]. 中国计划生育学杂志,2022,30(12):2807-2811. DOI:10.3969/j.issn.1004-8189.2022.12.029.

[10]倪瑞珺,黄宏丽,夏艳秋,等. 补肾活血方治疗早发性卵巢功能不全患者围绝经期症状的临床预测模型构建[J]. 中医杂志,2022,63(17):1654-1661. DOI:10.13288/j.11-2166/r.2022.17.011.

[11]郑维秀,肖丽珍,廖薇薇,等. 滋肾育胎丸治疗黄体功能不全所致复发性流产对患者子宫内膜容受性改善效果[J]. 中国计划生育学杂志,2023,31(9):2059-2062. DOI:10.3969/j.issn.1004-8189.2023.09.010.

[12]张亚伟,康晓迪,郝文静,等. 地屈孕酮联合口服黄体酮胶丸对黄体功能不全先兆流产患者血清抑制素A、性激素的影响[J]. 现代生物医学进展,2022,22(4):669-673. DOI:10.13241/j.cnki.pmb.2022.04.015.

[13]位菊峰,杨琳琳,方辉,等. 滋肾育胎丸联合黄体酮治疗黄体功能不全型先兆流产的疗效观察[J]. 世界中医药,2022,17(15):2195-2198. DOI:10.3969/j.issn.1673-7202. 2022.15.019.

[14]孙娇,刘晓燕. 胎宝汤治疗脾肾阳虚型滑胎患者临床疗效及对患者人绒毛膜促性腺激素和雌孕激素的影响分析[J]. 贵州医药,2022,46(8):1259-1260. DOI:10.3969/j.issn. 1000-744X.2022.08.051.

[15]田敏,陈嫣. 补肾养血安胎汤联合地屈孕酮对先兆流产患者TT3水平血清E2水平及继续妊娠率的影响[J]. 中国妇幼保健,2022,37(5):864-867. DOI:10.19829/j.zgfybj.issn. 1001-4411.2022.05.027.

[16]李海峰,杜二球. 保胎灵胶囊联合地屈孕酮对先兆流产患者孕酮人绒毛膜促性腺激素水平及凝血功能的影响[J]. 中国妇幼保健,2022,37(15):2830-2833. DOI:10.19829/j.zgfybj.issn.1001-4411.2022.15.032.

[17]任亚娟,林青,孙青凤,等. 脱花煎加减配合米索前列醇治疗不完全流产的效果[J]. 中华中医药学刊,2023,41(2):205-209. DOI:10.13193/j.issn.1673-7717.2023.02.046.

[18]王瑛,张静,马斐飞. 地屈孕酮联合戊酸雌二醇片对先兆流产患者激素水平血流动力学及妊娠结局的影响[J]. 中国妇幼保健,2022,37(16):3013-3017. DOI:10.19829/j.zgfybj.issn.1001-4411.2022.16.030.

[19]廖泽兰,杨志玲. 泰山磐石散加减结合地屈孕酮对气血两虚型习惯性流产妊娠影响研究[J]. 中华中医药学刊,2022,40(1):200-203. DOI:10.13193/j.issn.1673-7717. 2022.01.048.

[20]陈香,周夫群. 杜仲颗粒联合地屈孕酮片治疗早期先兆流产肾虚证临床研究[J]. 新中医,2022,54(10):129-132. DOI:10.13457/j.cnki.jncm.2022.10.030.

[21]仝建,王琳,黄钰景. 益肾壮母汤辅助治疗不明原因复发性流产对患者免疫、凝血及炎症状态的影响[J]. 中国计划生育学杂志,2022,30(5):1013-1017. DOI:10.3969/j.issn. 1004-8189.2022.05.010.